Inactive Instrument
Tobira Therapeutics Inc Stock
Stocks
US88883P1012
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Michael
CEO | Chief Executive Officer | 55 | - |
Scott Reents
DFI | Director of Finance/CFO | 59 | - |
| Corporate Secretary | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.16% | -0.30% | +58.96% | +94.17% | 71.53B | |
| -0.19% | -1.01% | +38.55% | +83.85% | 60.12B | |
| -1.51% | +2.20% | +10.66% | +35.15% | 48.85B | |
| -0.05% | +0.37% | +41.54% | +38.67% | 44.28B | |
| +0.38% | +7.61% | +339.53% | +684.33% | 43.83B | |
| +0.18% | +0.26% | +7.41% | +105.01% | 41.53B | |
| -0.67% | -0.45% | +4.47% | +46.37% | 30.13B | |
| +4.77% | +6.46% | +41.54% | +22.78% | 27.98B | |
| -1.29% | -3.55% | -20.74% | +349.90% | 25.25B | |
| Average | +0.69% | +0.48% | +57.99% | +162.25% | 43.72B | |
| Weighted average by Cap. | +0.85% | +0.63% | +63.17% | +153.57% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
